These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5067822)

  • 61. Hemagglutination and cytotoxic studies of H-2. 3. A family of 3-like specificities not in the C crossover region.
    Démant P; Snell GD; Cherry M
    Transplantation; 1971 Mar; 11(3):242-59. PubMed ID: 5558560
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study of streptococcal delayed hypersensitivity in rabbits].
    Zakarian SA
    Zh Eksp Klin Med; 1973; 13(3):32-6. PubMed ID: 4791713
    [No Abstract]   [Full Text] [Related]  

  • 63. Blood platelets in HL-A serology.
    Colombani J
    Transplant Proc; 1971 Jun; 3(2):1078-87. PubMed ID: 5134491
    [No Abstract]   [Full Text] [Related]  

  • 64. Extraction and purification of soluble HL-A antigens from exhausted media of human lymphoid cell lines.
    Pellegrino MA; Pellegrino A; Ferrone S; Kahan BD; Reisfeld RA
    J Immunol; 1973 Sep; 111(3):783-8. PubMed ID: 4741297
    [No Abstract]   [Full Text] [Related]  

  • 65. The role of D-alanine in the antigenic specificity of bacterial mucopeptides.
    Karakawa WW; Maurer PH; Walsh P; Krause RM
    J Immunol; 1970 Jan; 104(1):230-7. PubMed ID: 5411504
    [No Abstract]   [Full Text] [Related]  

  • 66. Anti-MHC xenoantisera and alloterminology.
    Sanderson AR; Thorsby E
    Transplantation; 1977 Jun; 23(6):525-6. PubMed ID: 325721
    [No Abstract]   [Full Text] [Related]  

  • 67. Nonspecific complement activation by streptococcal structures. I. Re-evaluation of HLA cytotoxicity inhibition.
    Tauber JW; Falk JA; Falk RE; Zabriskie JB
    J Exp Med; 1976 Jun; 143(6):1341-51. PubMed ID: 818334
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphocyte transformation in vitro. II. Mixed lymphocyte culture in relation to leucocyte antigens.
    Schellekens PT; Vriesendorp B; Eijsvoogel VP; Van Leeuwen A; Van Rood JJ; Miggiano V; Ceppellini R
    Clin Exp Immunol; 1970 Feb; 6(2):241-54. PubMed ID: 5435718
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
    Påhlman LI; Olin AI; Darenberg J; Mörgelin M; Kotb M; Herwald H; Norrby-Teglund A
    Cell Microbiol; 2008 Feb; 10(2):404-14. PubMed ID: 17900297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The high incidence of anti-HL-A antibodies in anti-D typing reagents. Illustrated by a case of Matuhasi-Ogata phenomenon mimicking a "D with anti-D" situation.
    Wilkinson SL; Vaithianathan T; Issitt PD
    Transfusion; 1974; 14(1):27-33. PubMed ID: 4204583
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hetero-immunization by myelomatous proteins. II. Demonstration of antigen heterogeneity at the level of human immunoglobulins gamma G1].
    Rivat C; Rivat L; Ropartz C
    Rev Fr Etud Clin Biol; 1969 May; 14(5):514-9. PubMed ID: 5819759
    [No Abstract]   [Full Text] [Related]  

  • 72. Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells.
    Watanabe T; Yagi Y; Pressman D
    J Immunol; 1971 May; 106(5):1213-21. PubMed ID: 5574404
    [No Abstract]   [Full Text] [Related]  

  • 73. [Definition of 2 new antigens of the HL-A system: Da 19 and Da 20. Cross reactions between the Da 19, Da 20, HL-A 5 and Da 6 antigens].
    Colombani M; Colombani J; Dastot H; Mayer S; Tongio MM; Dausset J
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):995-1003. PubMed ID: 5377894
    [No Abstract]   [Full Text] [Related]  

  • 74. Lymphocyte isoantibodies in autoallergic and dysgammaglobulinemic states.
    Waters H; Smith GS; Tanaka KR; Fishkin B; Walford RL
    Transplant Proc; 1971 Mar; 3(1):145-8. PubMed ID: 5095882
    [No Abstract]   [Full Text] [Related]  

  • 75. Enzyme-activation by antibody. II. The distribution of activating antibody in chromatographic fractions of ribonuclease antisera and their competition with inhibiting antibody for enzyme sites.
    Pelichová H; Suzuki T; Cinader B
    J Immunol; 1970 Jan; 104(1):195-202. PubMed ID: 5411503
    [No Abstract]   [Full Text] [Related]  

  • 76. Genetic aspects of human HL-A transplantation antigens.
    Amos DB
    Fed Proc; 1970; 29(6):2018-25. PubMed ID: 5482723
    [No Abstract]   [Full Text] [Related]  

  • 77. Purification of two fragments of M protein from a strain of group A, type 12 streptococcus.
    Johnson RH; Vosti KL
    J Immunol; 1968 Sep; 101(3):381-91. PubMed ID: 5676184
    [No Abstract]   [Full Text] [Related]  

  • 78. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lymphocyte transformation induced by culture media supplemented with primate serum.
    Burgess BJ; Vos GH; Grobbelaar BG
    J Med Primatol; 1973; 2(5):308-12. PubMed ID: 4207409
    [No Abstract]   [Full Text] [Related]  

  • 80. Red cell-sensitizing antigen of group A streptococci. I. Biological and chemical properties.
    Ne'eman N; Ginsburg I
    Isr J Med Sci; 1972 Nov; 8(11):1799-806. PubMed ID: 4647208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.